Table 1.
Demographic and clinical characteristics of 673 patients.
| Variables | n |
|---|---|
| Age, y (mean ± SD) | 63.21 ± 10.24 |
| BMI (mean ± SD) | 25.72 ± 2.57 |
| Menopausal patients (%) | 578 (85.9) |
| Hormonal Replacement Therapy (%)a | 165 (28.6) |
| Local Estrogen therapy (%)a | 223 (38.6) |
| Parity (range) | 2 (0–3) |
| Smoke (%) | 94 (13.9) |
| Previous pelvic surgery (%) | 112 (16.6) |
| Ongoing treatments | |
| Pelvic floor rehabilitation (%) | 165 (24.5) |
| Nutraceuticals (%) | 154 (22.9) |
| Pharmacologic treatment (%) | 259 (38.5) |
| Peripherical tibial nerve stimulation (PTNS) (%) | 27 (4) |
| Sacral Neuromodulation (SNM) (%) | 40 (5.9) |
| Intradetrusor onabotulinumtoxin A injections (BoNT-A) (%) | 28 (4.2) |
Abbreviation: SD: Standard Deviation; BMI: Body Mass Index.
a
The percentage is calculated on menopausal patients.